228 related articles for article (PubMed ID: 24979808)
1. Engineering ePTEN, an enhanced PTEN with increased tumor suppressor activities.
Nguyen HN; Yang JM; Afkari Y; Park BH; Sesaki H; Devreotes PN; Iijima M
Proc Natl Acad Sci U S A; 2014 Jul; 111(26):E2684-93. PubMed ID: 24979808
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of human PTEN localization revealed by heterologous expression in Dictyostelium.
Nguyen HN; Afkari Y; Senoo H; Sesaki H; Devreotes PN; Iijima M
Oncogene; 2014 Dec; 33(50):5688-96. PubMed ID: 24292679
[TBL] [Abstract][Full Text] [Related]
3. A new class of cancer-associated PTEN mutations defined by membrane translocation defects.
Nguyen HN; Yang JM; Rahdar M; Keniry M; Swaney KF; Parsons R; Park BH; Sesaki H; Devreotes PN; Iijima M
Oncogene; 2015 Jul; 34(28):3737-43. PubMed ID: 25263454
[TBL] [Abstract][Full Text] [Related]
4. Engineering PTEN function: membrane association and activity.
Yang JM; Nguyen HN; Sesaki H; Devreotes PN; Iijima M
Methods; 2015 May; 77-78():119-24. PubMed ID: 25448479
[TBL] [Abstract][Full Text] [Related]
5. Mutual inhibition between PTEN and PIP3 generates bistability for polarity in motile cells.
Matsuoka S; Ueda M
Nat Commun; 2018 Oct; 9(1):4481. PubMed ID: 30367048
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide and L-cysteine increase phosphatidylinositol 3,4,5-trisphosphate (PIP3) and glucose utilization by inhibiting phosphatase and tensin homolog (PTEN) protein and activating phosphoinositide 3-kinase (PI3K)/serine/threonine protein kinase (AKT)/protein kinase Cζ/λ (PKCζ/λ) in 3T3l1 adipocytes.
Manna P; Jain SK
J Biol Chem; 2011 Nov; 286(46):39848-59. PubMed ID: 21953448
[TBL] [Abstract][Full Text] [Related]
7. A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth.
Denning G; Jean-Joseph B; Prince C; Durden DL; Vogt PK
Oncogene; 2007 Jun; 26(27):3930-40. PubMed ID: 17213812
[TBL] [Abstract][Full Text] [Related]
8. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors.
Kwon J; Lee SR; Yang KS; Ahn Y; Kim YJ; Stadtman ER; Rhee SG
Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16419-24. PubMed ID: 15534200
[TBL] [Abstract][Full Text] [Related]
9. PI(3)king apart PTEN's role in cancer.
Zhang S; Yu D
Clin Cancer Res; 2010 Sep; 16(17):4325-30. PubMed ID: 20622047
[TBL] [Abstract][Full Text] [Related]
10. CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction.
Yeung YT; Fan S; Lu B; Yin S; Yang S; Nie W; Wang M; Zhou L; Li T; Li X; Bode AM; Dong Z
Carcinogenesis; 2020 May; 41(3):377-389. PubMed ID: 31241130
[TBL] [Abstract][Full Text] [Related]
11. Co-existence of high levels of the PTEN protein with enhanced Akt activation in renal cell carcinoma.
He L; Fan C; Gillis A; Feng X; Sanatani M; Hotte S; Kapoor A; Tang D
Biochim Biophys Acta; 2007 Oct; 1772(10):1134-42. PubMed ID: 17681738
[TBL] [Abstract][Full Text] [Related]
12. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway.
Tamura M; Gu J; Danen EH; Takino T; Miyamoto S; Yamada KM
J Biol Chem; 1999 Jul; 274(29):20693-703. PubMed ID: 10400703
[TBL] [Abstract][Full Text] [Related]
13. Imatinib mesilate-induced phosphatidylinositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 5'-phosphatase interaction with c-Abl.
Mokhtari D; Al-Amin A; Turpaev K; Li T; Idevall-Hagren O; Li J; Wuttke A; Fred RG; Ravassard P; Scharfmann R; Tengholm A; Welsh N
Diabetologia; 2013 Jun; 56(6):1327-38. PubMed ID: 23462796
[TBL] [Abstract][Full Text] [Related]
14. PIP3 waves and PTEN dynamics in the emergence of cell polarity.
Gerisch G; Schroth-Diez B; Müller-Taubenberger A; Ecke M
Biophys J; 2012 Sep; 103(6):1170-8. PubMed ID: 22995489
[TBL] [Abstract][Full Text] [Related]
15. Phospholipase C regulation of phosphatidylinositol 3,4,5-trisphosphate-mediated chemotaxis.
Kortholt A; King JS; Keizer-Gunnink I; Harwood AJ; Van Haastert PJ
Mol Biol Cell; 2007 Dec; 18(12):4772-9. PubMed ID: 17898079
[TBL] [Abstract][Full Text] [Related]
16. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.
Reed DE; Shokat KM
Mol Cancer Res; 2017 Jun; 15(6):765-775. PubMed ID: 28196852
[TBL] [Abstract][Full Text] [Related]
17. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
[TBL] [Abstract][Full Text] [Related]
18. PTEN, more than the AKT pathway.
Blanco-Aparicio C; Renner O; Leal JF; Carnero A
Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655
[TBL] [Abstract][Full Text] [Related]
19. PTEN and myotubularin: novel phosphoinositide phosphatases.
Maehama T; Taylor GS; Dixon JE
Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
[TBL] [Abstract][Full Text] [Related]
20. Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and tumorigenic transformation.
Okahara F; Itoh K; Nakagawara A; Murakami M; Kanaho Y; Maehama T
Mol Biol Cell; 2006 Nov; 17(11):4888-95. PubMed ID: 16971513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
